Nutrien (NYSE:NTR – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Royal Bank of Canada in a report released on Monday,Benzinga reports. They currently have a $60.00 price objective on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 15.45% from the stock’s current price.
Other equities analysts have also recently issued research reports about the stock. CIBC reaffirmed an “outperformer” rating and set a $55.00 price objective (down previously from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Barclays reissued an “equal weight” rating and set a $56.00 target price (up previously from $55.00) on shares of Nutrien in a research note on Tuesday, January 21st. JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and increased their price target for the stock from $40.00 to $50.00 in a research report on Monday, January 13th. UBS Group lifted their price objective on shares of Nutrien from $53.00 to $54.00 and gave the company a “neutral” rating in a report on Thursday. Finally, Wells Fargo & Company raised their price target on shares of Nutrien from $53.00 to $56.00 and gave the company an “equal weight” rating in a research report on Friday. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $59.50.
Read Our Latest Stock Report on NTR
Nutrien Trading Down 1.2 %
Nutrien (NYSE:NTR – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The business had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. On average, sell-side analysts predict that Nutrien will post 3.72 EPS for the current fiscal year.
Institutional Investors Weigh In On Nutrien
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio grew its stake in shares of Nutrien by 6.3% in the 4th quarter. Public Employees Retirement System of Ohio now owns 92,018 shares of the company’s stock valued at $4,116,000 after purchasing an additional 5,420 shares during the last quarter. Burgundy Asset Management Ltd. raised its position in Nutrien by 36.1% during the 4th quarter. Burgundy Asset Management Ltd. now owns 130,000 shares of the company’s stock worth $5,811,000 after buying an additional 34,500 shares during the last quarter. Vise Technologies Inc. purchased a new stake in shares of Nutrien in the fourth quarter valued at about $222,000. Two Sigma Advisers LP increased its stake in shares of Nutrien by 211.4% during the fourth quarter. Two Sigma Advisers LP now owns 67,317 shares of the company’s stock worth $3,012,000 after acquiring an additional 45,700 shares during the period. Finally, Two Sigma Investments LP increased its stake in shares of Nutrien by 45.7% during the fourth quarter. Two Sigma Investments LP now owns 301,505 shares of the company’s stock worth $13,492,000 after acquiring an additional 94,554 shares during the period. 63.10% of the stock is owned by hedge funds and other institutional investors.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles
- Five stocks we like better than Nutrien
- Why Are Stock Sectors Important to Successful Investing?
- 3 Beaten Down Healthcare Stocks Recovering in 2025
- Most active stocks: Dollar volume vs share volume
- These 3 Unusual ETFs Have Dominated the S&P 500’s Performance YTD
- What Is WallStreetBets and What Stocks Are They Targeting?
- UnitedHealth’s RSI Suggests It Is Extremely Oversold
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.